Ascend Laboratories LLC is recalling 34,296 bottles of Olmesartan Medoxomil tablets (20 mg), a medication used to treat high blood pressure. The recall was issued because a foreign tablet or capsule was discovered inside a bottle of the product. Ingesting an unidentified or incorrect medication can lead to serious health risks, including unintended side effects or lack of proper treatment for your condition. The affected products were distributed nationwide in 30-count bottles and were manufactured by Alkem Laboratories Ltd.
The presence of a foreign tablet or capsule means consumers may accidentally ingest the wrong medication. This poses a risk of adverse drug reactions or potential interactions with other medications the patient may be taking.
Return for refund and pharmacist consultation.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.